Biotech Blog Archives: July 2003
next page ·
23 July 2003
Antibiotics, The Next Generation
Antibiotics, The Next Generation
Few things are as inexorable as the march of bacterial resistance. When a person or animal is given an antibiotic, it kills enough pathogens to cure the illness. But bacteria that have mutated so they can resist the drug survive. The next time these bacteria cause an infection, the antibiotic is less [...]
continue reading... » 0 Comments
22 July 2003
The War against ‘Viagra’
The War against ‘Viagra’
The US Food and Drug Administration has announced plans to fight counterfeit drugs. The FDA will introduce technology that could show at a glance if drugs are real, such as watermarks or electronic tags. It will also tighten requirements for drug wholesalers so it’s tougher to sneak counterfeits into legitimate supplies.
continue reading... » 0 Comments
22 July 2003
BIO leader hits proposal for drug price regulation
BIO leader hits proposal for drug price regulation
The Cambridge-based chairman of the nation’s largest biotech organization is strongly opposing any federal controls in drug pricing if a prescription drug component is added to Medicare.
“It’s price controls or innovation; you can’t have both,” said Richard Pops, who recently was elected to head the board of directors [...]
continue reading... » 0 Comments
22 July 2003
Biotech industry in survival mode
Biotech industry in survival mode
Restructuring, retrenching and reinventing themselves, Bay Area biotechnology firms are adapting to weather the economic downturn.
…
“We’ve noticed (biotech companies) will abandon one or two research products and in the process may have discovered something of more use, readjusting their core competency to find something marketable today, rather than long term”
continue reading... » 0 Comments
22 July 2003
The genetically-modified food fight
The genetically-modified food fight
Once again, Europe and the U.S. are at loggerheads. This time, they’re fighting over food, not foreign policy. On July 2, the European Parliament passed legislation calling for detailed labeling of genetically modified (GM) food products.
continue reading... » 0 Comments
21 July 2003
No simple generic answer
No simple generic answer
Unlike pills and capsules that are brewed from a mixture of chemicals, injectable therapies like hormones and genetically engineered proteins are not covered by the Hatch-Waxman Act, the 1984 law that laid the foundation for the nation’s generic drug industry. That has left brand-name biotech manufacturers with the hope of monopolies well [...]
